NPAORF v4.0 | National Pharmaceutical Asset Optimization & Resilience Framework

Genesis Mission AI (2025) FDA/EMA Aligned 21 CFR Part 11

Predicting Failures.
Preventing Shortages.
Protecting Lives.

NPAORF is an AI-powered predictive maintenance platform preventing the equipment failures that cause 40% of all drug shortages.

0+

Active Drug Shortages

ASHP Jan 2026

$0M

Annual Hospital Costs

Managing Shortages

0+

Days Early Warning

Before Failure

0%

Equipment Uptime

vs 89% Industry Avg

Universal Equipment Configuration

Hardware-agnostic framework for ANY U.S. pharmaceutical facility

Kazmi Methodology™

Bioreactors

Chromatography

ULT Freezers

Filling Lines

Select equipment above to see configuration

Geographic Coverage

National Monitoring Network

Live Dashboard

Drug Shortage Intelligence Center

Showing 25 of 25

State

Shortages by Category

Risk Distribution

12-Month Shortage Trend

Without NPAORF With NPAORF

Drug Shortage Database

Source: ASHP January 2026

Drug Name ↕	Category ↕	State	Equipment	Health ↕	Risk ↕	Trend

Equipment Intelligence

Real-Time Asset Monitoring

Technical Architecture

AI/ML Methodology

The Kazmi Methodology™ - Four-stage predictive maintenance pipeline

1

Data Ingestion

24/7 real-time sensor streaming: vibration, temperature, pressure, runtime.

OPC-UAMQTTREST API

2

Feature Engineering

150+ engineered features: rolling stats, FFT, wavelets, lag variables.

FFTPCAWavelet

3

ML Prediction

Hybrid ensemble: XGBoost classification + LSTM time-series forecasting.

XGBoostLSTMAttention

4

Actionable Alerts

Explainable AI with SHAP attribution and CMMS integration.

SHAPCMMSSAP PM

94.7%

Model Accuracy

14.2

Days Lead Time

2.3%

False Positive Rate

<50ms

Inference Latency

LSTM Time-Series Architecture

The Long Short-Term Memory (LSTM) network captures temporal degradation patterns:

Input: 72-hour sliding window of multivariate sensor data
Hidden: 2 stacked LSTM layers (128, 64 units) with dropout (0.3)
Attention: Self-attention to weight critical time steps
Output: Dense layer with sigmoid for failure probability [0,1]

# Kazmi Methodology - LSTM
model = Sequential([
    LSTM(128, return_sequences=True,
         input_shape=(window, features)),
    Dropout(0.3),
    LSTM(64),
    Dropout(0.3),
    Dense(32, activation='relu'),
    Dense(1, activation='sigmoid')
])

Economic Impact Analysis

National Value Calculator

Quantify the economic benefit using FDA/ASHP January 2026 data

Data Sources: FDA & ASHP Drug Shortage Reports

January 2026 | 323 Active Shortages | $900M Annual National Burden

Deployment Scenario

Assets Monitored2,500

10015,000

Downtime Hours Prevented/Asset/Year150

10500

Industry Baseline: Pharma R&D downtime costs $540,000/hour

Batch Economics: Sterile injectable batch value: $2.5M

U.S. R&D Capital Preserved

$202.5B

≈ 405,000 Phase III clinical trials

22

Shortage Days Prevented

2.4M

Patient Days Saved

Projected National Healthcare Savings

FDA/ASHP 2026

$187.5M

4,500

Batches Protected

$22.5M

Hospital Burden Avoided

Federal Impact Assessment

1,035

patient lives

Potentially impacted through shortage prevention

18 shortages preventable 2.3% mortality reduction

National Shortage Burden Addressed24.3%

Of $900M annual national shortage burden (ASHP Jan 2026)

21 CFR Part 11 Compliant

Secure Audit Trail

Immutable record with cryptographic verification

ALCOA+ Verified

Tamper-Evident

e-Signature Ready

Total Records:0

System Event Log

RECORDING

Timestamp (UTC)	User ID	Event Type	Action Description	SHA-256 Checksum	Status

Regulatory Reference

Compliance Guide

FDA/EMA AI Guidance and 21 CFR Part 11 documentation

FDA/EMA AI Credibility Principles (January 2026)

ALCOA+ Data Integrity

Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring

✓ Compliant

21 CFR Part 11

Electronic records, signatures, audit trails, system validation, access controls

✓ Compliant

Model Versioning

Full reproducibility with MLflow tracking, model registry, artifact management

✓ Compliant

21 CFR Part 11 Compliance Matrix

Requirement	Section	NPAORF Implementation	Status
Audit Trail	§11.10(e)	Immutable event log with SHA-256 checksums	PASS
Electronic Signatures	§11.100	Unique user ID + authentication code + meaning	PASS
Access Controls	§11.10(d)	Role-based access with MFA authentication	PASS
Record Integrity	§11.10(c)	Cryptographic hashing prevents tampering	PASS
System Validation	§11.10(a)	IQ/OQ/PQ documentation with validation logs	PASS

Genesis Mission AI (White House 2025)

NPAORF is aligned with the White House Genesis Mission initiative for trustworthy AI:

Transparency

SHAP explainability for all predictions

Accountability

Full audit trail with digital signatures

Fairness

Bias monitoring across equipment types

Security

End-to-end encryption and access control

Predicting Failures. Preventing Shortages. Protecting Lives.

Universal Equipment Configuration

National Monitoring Network

Drug Shortage Intelligence Center

Shortages by Category

Risk Distribution

12-Month Shortage Trend

Drug Shortage Database

Real-Time Asset Monitoring

AI/ML Methodology

Data Ingestion

Feature Engineering

ML Prediction

Actionable Alerts

LSTM Time-Series Architecture

National Value Calculator

Deployment Scenario

Secure Audit Trail

System Event Log

Digital Signature Required

Compliance Guide

FDA/EMA AI Credibility Principles (January 2026)

ALCOA+ Data Integrity

21 CFR Part 11

Model Versioning

21 CFR Part 11 Compliance Matrix

Genesis Mission AI (White House 2025)

Transparency

Accountability

Fairness

Security

Predicting Failures.
Preventing Shortages.
Protecting Lives.